Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma

Histopathology. 2018 Apr;72(5):739-748. doi: 10.1111/his.13422. Epub 2018 Jan 5.

Abstract

Aims: The aim of this study was to identify the prognostic factors of uterine leiomyosarcoma (ULMS).

Methods and results: We reviewed 60 cases of surgically resected ULMSs and investigated conventional clinicopathological factors, together with the expression of insulin-like growth factor II messenger RNA-binding protein-3 (IMP3), hormone receptors and cell cycle regulatory markers by immunohistochemistry. Mediator complex subunit 12 (MED12) mutation analysis was also performed. Univariate analyses revealed that advanced stage (P < 0.0001), older age (P = 0.0244) and IMP3 expression (P = 0.0011) were significant predictors of a poor outcome. Multivariate analysis revealed advanced stage (P < 0.0001) and IMP3 (P = 0.0373) as independent predictors of a poor prognosis. Expressions of cell cycle markers and hormone receptors, and MED12 mutations (12% in ULMSs) were not identified as prognostic markers in this study.

Conclusions: IMP3 expression in ULMS could be a marker of a poor prognosis.

Keywords: MED12; IMP3; leiomyosarcoma; prognosis; uterus.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Leiomyosarcoma / metabolism
  • Leiomyosarcoma / mortality
  • Leiomyosarcoma / pathology*
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • RNA-Binding Proteins / biosynthesis*
  • Uterine Neoplasms / metabolism
  • Uterine Neoplasms / mortality
  • Uterine Neoplasms / pathology*
  • Young Adult

Substances

  • Biomarkers, Tumor
  • IGF2BP3 protein, human
  • RNA-Binding Proteins